vs

Side-by-side financial comparison of American Assets Trust, Inc. (AAT) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $110.6M, roughly 1.8× American Assets Trust, Inc.). REPLIGEN CORP runs the higher net margin — 6.7% vs 6.1%, a 0.6% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs 1.8%). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs -0.1%).

Personal Assets Trust is a large British investment trust. The company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. The chairman is Iain Ferguson CBE.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

AAT vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.8× larger
RGEN
$197.9M
$110.6M
AAT
Growing faster (revenue YoY)
RGEN
RGEN
+11.8% gap
RGEN
13.6%
1.8%
AAT
Higher net margin
RGEN
RGEN
0.6% more per $
RGEN
6.7%
6.1%
AAT
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
-0.1%
AAT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AAT
AAT
RGEN
RGEN
Revenue
$110.6M
$197.9M
Net Profit
$6.7M
$13.3M
Gross Margin
52.5%
Operating Margin
23.4%
9.0%
Net Margin
6.1%
6.7%
Revenue YoY
1.8%
13.6%
Net Profit YoY
-16.3%
143.9%
EPS (diluted)
$0.08
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AAT
AAT
RGEN
RGEN
Q1 26
$110.6M
Q4 25
$110.1M
$197.9M
Q3 25
$109.6M
$188.8M
Q2 25
$107.9M
$182.4M
Q1 25
$108.6M
$169.2M
Q4 24
$113.5M
$174.1M
Q3 24
$122.8M
$154.9M
Q2 24
$110.9M
$154.1M
Net Profit
AAT
AAT
RGEN
RGEN
Q1 26
$6.7M
Q4 25
$13.3M
Q3 25
$4.5M
$14.9M
Q2 25
$5.5M
$14.9M
Q1 25
$42.5M
$5.8M
Q4 24
$-30.3M
Q3 24
$16.7M
$-654.0K
Q2 24
$11.9M
$3.3M
Gross Margin
AAT
AAT
RGEN
RGEN
Q1 26
Q4 25
59.4%
52.5%
Q3 25
60.5%
53.2%
Q2 25
62.6%
50.0%
Q1 25
62.0%
53.6%
Q4 24
61.3%
26.1%
Q3 24
65.5%
50.0%
Q2 24
63.6%
49.8%
Operating Margin
AAT
AAT
RGEN
RGEN
Q1 26
23.4%
Q4 25
21.1%
9.0%
Q3 25
22.6%
8.9%
Q2 25
24.1%
7.6%
Q1 25
66.3%
3.9%
Q4 24
26.5%
-17.7%
Q3 24
30.8%
-5.1%
Q2 24
27.8%
1.0%
Net Margin
AAT
AAT
RGEN
RGEN
Q1 26
6.1%
Q4 25
6.7%
Q3 25
4.1%
7.9%
Q2 25
5.1%
8.2%
Q1 25
39.2%
3.4%
Q4 24
-17.4%
Q3 24
13.6%
-0.4%
Q2 24
10.7%
2.2%
EPS (diluted)
AAT
AAT
RGEN
RGEN
Q1 26
$0.08
Q4 25
$0.06
$0.24
Q3 25
$0.07
$0.26
Q2 25
$0.09
$0.26
Q1 25
$0.70
$0.10
Q4 24
$0.14
$-0.55
Q3 24
$0.28
$-0.01
Q2 24
$0.20
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AAT
AAT
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$118.3M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$1.1B
$2.1B
Total Assets
$2.9B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AAT
AAT
RGEN
RGEN
Q1 26
$118.3M
Q4 25
$129.4M
$767.6M
Q3 25
$138.7M
$748.7M
Q2 25
$143.7M
$708.9M
Q1 25
$143.9M
$697.2M
Q4 24
$425.7M
$757.4M
Q3 24
$533.0M
$784.0M
Q2 24
$114.9M
$809.1M
Total Debt
AAT
AAT
RGEN
RGEN
Q1 26
Q4 25
$1.7B
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$2.0B
$525.6M
Q3 24
Q2 24
Stockholders' Equity
AAT
AAT
RGEN
RGEN
Q1 26
$1.1B
Q4 25
$1.2B
$2.1B
Q3 25
$1.2B
$2.1B
Q2 25
$1.2B
$2.1B
Q1 25
$1.2B
$2.0B
Q4 24
$1.2B
$2.0B
Q3 24
$1.2B
$2.0B
Q2 24
$1.2B
$2.0B
Total Assets
AAT
AAT
RGEN
RGEN
Q1 26
$2.9B
Q4 25
$2.9B
$2.9B
Q3 25
$2.9B
$2.9B
Q2 25
$3.0B
$2.9B
Q1 25
$3.0B
$2.9B
Q4 24
$3.3B
$2.8B
Q3 24
$3.4B
$2.8B
Q2 24
$3.0B
$2.9B
Debt / Equity
AAT
AAT
RGEN
RGEN
Q1 26
Q4 25
1.48×
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
1.72×
0.27×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AAT
AAT
RGEN
RGEN
Operating Cash FlowLast quarter
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
14.5%
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AAT
AAT
RGEN
RGEN
Q1 26
Q4 25
$167.1M
$25.7M
Q3 25
$40.5M
$48.1M
Q2 25
$49.2M
$28.6M
Q1 25
$36.9M
$15.0M
Q4 24
$207.1M
$39.2M
Q3 24
$52.4M
$49.3M
Q2 24
$59.3M
$42.2M
Free Cash Flow
AAT
AAT
RGEN
RGEN
Q1 26
Q4 25
$94.9M
$17.6M
Q3 25
$23.1M
$43.4M
Q2 25
$28.4M
$21.5M
Q1 25
$20.4M
$11.4M
Q4 24
$136.9M
$33.6M
Q3 24
$28.0M
$42.3M
Q2 24
$43.6M
$37.4M
FCF Margin
AAT
AAT
RGEN
RGEN
Q1 26
Q4 25
86.2%
8.9%
Q3 25
21.1%
23.0%
Q2 25
26.3%
11.8%
Q1 25
18.8%
6.8%
Q4 24
120.7%
19.3%
Q3 24
22.8%
27.3%
Q2 24
39.3%
24.3%
Capex Intensity
AAT
AAT
RGEN
RGEN
Q1 26
14.5%
Q4 25
65.6%
4.1%
Q3 25
15.9%
2.5%
Q2 25
19.3%
3.9%
Q1 25
15.1%
2.1%
Q4 24
61.9%
3.2%
Q3 24
19.9%
4.5%
Q2 24
14.1%
3.1%
Cash Conversion
AAT
AAT
RGEN
RGEN
Q1 26
Q4 25
1.93×
Q3 25
8.98×
3.23×
Q2 25
9.01×
1.92×
Q1 25
0.87×
2.57×
Q4 24
Q3 24
3.15×
Q2 24
4.98×
12.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AAT
AAT

Rental income$104.4M94%
Other$6.2M6%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons